Harwood Advisory Group LLC Purchases 1,035 Shares of Clorox Co (NYSE:CLX)
Harwood Advisory Group LLC grew its position in shares of Clorox Co (NYSE:CLX) by 12.4% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,370 shares of the company’s stock after purchasing an additional 1,035 shares during the quarter. Harwood Advisory Group LLC’s holdings in Clorox were worth $1,423,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Heritage Wealth Advisors bought a new position in Clorox during the 2nd quarter worth approximately $30,000. Transamerica Financial Advisors Inc. bought a new position in Clorox during the 2nd quarter worth approximately $41,000. Mirova bought a new position in Clorox during the 2nd quarter worth approximately $47,000. Nelson Van Denburg & Campbell Wealth Management Group LLC raised its holdings in Clorox by 45.9% during the 3rd quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 334 shares of the company’s stock worth $50,000 after purchasing an additional 105 shares during the last quarter. Finally, Prestige Wealth Management Group LLC bought a new position in Clorox during the 2nd quarter worth approximately $53,000. Hedge funds and other institutional investors own 78.46% of the company’s stock.
Several research firms have issued reports on CLX. Bank of America lowered their price target on shares of Clorox from $165.00 to $160.00 and set a “neutral” rating for the company in a report on Thursday, October 3rd. Morgan Stanley restated an “underweight” rating and set a $134.00 price target (down previously from $144.00) on shares of Clorox in a report on Monday, September 30th. Royal Bank of Canada lifted their price objective on shares of Clorox to $161.00 and gave the company a “sector perform” rating in a research note on Friday, August 2nd. Barclays reiterated a “sell” rating on shares of Clorox in a research note on Friday, October 4th. Finally, Citigroup lowered their price objective on shares of Clorox from $167.00 to $163.00 and set a “neutral” rating for the company in a research note on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the stock. Clorox currently has a consensus rating of “Hold” and an average target price of $152.25.
Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, August 1st. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.04. The company had revenue of $1.63 billion during the quarter, compared to analyst estimates of $1.69 billion. Clorox had a net margin of 13.20% and a return on equity of 118.88%. Clorox’s revenue for the quarter was down 3.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.66 EPS. Research analysts expect that Clorox Co will post 6.14 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Wednesday, October 30th will be paid a dividend of $1.06 per share. The ex-dividend date is Tuesday, October 29th. This represents a $4.24 dividend on an annualized basis and a yield of 2.86%. Clorox’s dividend payout ratio (DPR) is presently 67.09%.
In other Clorox news, Director A D. David Mackay sold 3,400 shares of the business’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $154.87, for a total transaction of $526,558.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Michael R. Costello sold 6,997 shares of the business’s stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $162.56, for a total transaction of $1,137,432.32. Following the sale, the senior vice president now owns 29,016 shares of the company’s stock, valued at approximately $4,716,840.96. The disclosure for this sale can be found here. Insiders have sold a total of 15,609 shares of company stock valued at $2,497,443 in the last 90 days. 1.14% of the stock is currently owned by company insiders.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
See Also: What is the Rule of 72?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.